Navigation Links
Vical Biotech and NIH jointly develops HIV vaccine

A new HIV vaccine is being jointly developed by Vical Pharmaceuticals and the National Institute of Health (NIH). The new HIV vaccine was developed by the scientistis in NIH and the Federal government is using the Vical Biotechs DNA delivery technology to inserting the HIV genes//.

Vical Inc. is a Biotechnology company based in California, which has developed an accurate DNA delivery system, last month Vical has agreed to grant Merck to use its gene delivery system technology for cancer vaccines in exchange for rights to use the technology for vaccines against HIV. The Phase 2 clinical trial is performed by HIV vaccine trial group of NIH, this technology incorporates 4 HIV genes and the NIH trial group evaluates and compares different HIV/AIDS vaccines.

The news sent shares of Vical up $1.16, or 21.60 percent, to $6.54 in morning trade on Nasdaq, after touching high of $6.98. The stock was among the biggest percentage gainers on Nasdaq.

Source: Reuters.
'"/>




Page: 1

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Biotechnology Initiatives Planned In Hyderabad
9. Biotech Osiris to go public
10. Western Region Tops in Indian Biotech Growth
11. Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vical Biotech and NIH jointly develops HIV vaccine

(Date:12/22/2014)... Harrisburg, NC (PRWEB) December 22, 2014 ... contain the current Ebola virus epidemic are ... by U.S. government agencies, nongovernmental organizations (NGOs) ... solutions remains ongoing, healthcare workers, emergency responders, ... advanced technologies such as the CmTP ...
(Date:12/22/2014)... new vaccine created to fight an illness similar to ... and even humans from similar brain infections, researchers report. ... becoming infected by the incurable brain disorder known as ... Dec. 21 online edition of the journal Vaccine ... particles known as prions that go rogue. Prion ...
(Date:12/22/2014)... December 22, 2014 The Bob ... ever, having invested more than $5 million in ... veterans and their families. , This includes $1.3 ... dozen nonprofits, helping with: veteran entrepreneurship; community impact; ... life-coaches for severely injured veterans. , “The needs ...
(Date:12/22/2014)... Explorys, the leader in big data-driven healthcare ... Greg Yarrington as Vice President of Operations, Adam Wallace ... Vice President of Solutions. These new leaders are part ... 2015 to support client demand for the company’s big ... growth of its partner network. , Since the ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Give a ... season, the gift of health and vitality. , For ... its three top-selling anti-aging formulas in special Holiday Wellness ... rush delivery. , Each bottle contains cutting-edge, proven ... that don't work as well as we age. ...
Breaking Medicine News(10 mins):Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Vaccine for Deer Against 'Mad Cow'-Like Illness Shows Promise 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2
... for bona fide media presenting official press credentials , ... facilities & IT support, English, Swedish, Spanish, German, and ... language is English] News briefings will be ... hrs CEST Monday 4 July (English), 14.00 hrs CEST ...
... more likely to suffer surgical site infections (SSIs) if the ... July issue of BJS, the British Journal of Surgery ... major abdominal surgery, exploring demographic parameters, the duration of the ... patients (17 per cent) developed SSIs and the only variable ...
... patients survive longer than Caucasians no matter how many drugs ... apparent both before and after the introduction of targeted therapies ... June issue of the Journal of Thoracic Oncology . ... of lung cancer, the non-small cell type, have a better ...
... Although gynecologic cancers account for only 10 percent of ... for 20 percent of all female cancer survivors. Because ... important to detect recurrence. The Clinical Practice Committee of ... Clinical Document outlining their expert recommendations for cancer surveillance, ...
... prior authorization for imaging services using proprietary algorithms to ... have the potential to either increase or decrease societal ... of the Journal of the American College of ... widely used by private payers to manage the utilization ...
... TUESDAY, May 31 (HealthDay News) -- Although many older diabetics ... fractures as people with osteoporosis, a new study finds. ... test to look for signs of bone loss and osteoporosis, ... with type 2 diabetes has been a question, according to ...
Cached Medicine News:Health News:European Society of Human Reproduction and Embryology Annual Meeting July 3-6, 2011, Stockholm 2Health News:European Society of Human Reproduction and Embryology Annual Meeting July 3-6, 2011, Stockholm 3Health News:Noisy operations associated with increased infections after surgery 2Health News:Asian lung cancer patient survival exceeds Caucasians' on multiple regimens 2Health News:SGO sets new standards to monitor recurrence of gynecologic cancer more effectively 2Health News:Radiology benefit managers adversely affect referring physicians, study suggests 2Health News:In Diabetics, Good Scores on Bone Tests May Not Rule Out Risk 2Health News:In Diabetics, Good Scores on Bone Tests May Not Rule Out Risk 3
(Date:12/19/2014)... , Dec. 19, 2014  Advanced Medical Isotope ... company engaged primarily in the development of brachytherapy ... applications, today announced that a Life Sciences Discovery ... awarded for which AMIC is the commercialization partner.  ... (WSU) for the proposal titled "Optimized Injectable Radiogels ...
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... how to optimize a product,s web presence to ... critical. Brand websites, in particular, must meet the ... in regulations and culture. According ... LLC, more than half of the participating companies ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Building a Best-in-Class Pharma Global Brand Website 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
... PITTSBURGH, Dec. 27, 2011 Mylan Inc. (Nasdaq: ... has received final approval from the U.S. Food and Drug ... Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base). ... ® Tablets, which are used to treat hypertension. ...
...   Losing weight and saving money: two of the ... toughest to stick with beyond mid-January. To help make achieving ... of dietary supplements and support products, is offering a few ... same time. "The New Year is all ...
Cached Medicine Technology:Mylan Launches First Generic Version of Teveten® Tablets 2Lose Weight and Save Money at the Same Time in the New Year 2Lose Weight and Save Money at the Same Time in the New Year 3Lose Weight and Save Money at the Same Time in the New Year 4
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: